Toward cost-effectiveness analysis in the diagnosis and treatment of insomnia

Sleep Medicine Reviews

Volumn 8, Issue 1, 2004, Pages 63-72

  Martin, Susan A ^a   Aikens, James E ^b   Chervin, Ronald D ^b  

^a PFIZER INC   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cost(s); Cost effectiveness analysis and utility utilities; Economics; Health related quality of life; Hypnotics; Insomnia; Sleep disturbance and maintenance disorders

Indexed keywords

ESTAZOLAM; FLURAZEPAM; QUAZEPAM; TEMAZEPAM; TRIAZOLAM; ZALEPLON; ZOLPIDEM;

BEHAVIOR THERAPY; COGNITIVE THERAPY; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH SERVICE; HUMAN; INSOMNIA; MEDLINE; PREVALENCE; QUALITY OF LIFE; REVIEW;

EID: 1542299208     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smrv.2003.08.001     Document Type: Article

References (51)

1. Kuppermann M, Lubeck DP, Mazonson PD, Patrick DL, Stewart AL, Buesching DP, Fifer SK. Sleep problems and their correlates in a working population. J Gen Intern Med 1995; 10: 25-32.
2. Ustun T, Privett M, Lecrubier Y, Weiller E, Simon G, Korten A, Bassett S, Maier W, Sartorius N. Form, frequency, and burden of sleep problems in general health care. Eur J Psychiatry 1996; 11 (Suppl 1): 5S-10S.
3. Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep 1999; 22(Suppl 2): S347-S353.
4. Morgan K, Clarke D. Risk factors for late-life insomnia in a representative general practice sample. Br J Gen Pract 1997; 47(416): 166-169.
5. Shochat T, Umphress J, Israel AG, Ancoli-Israel S. Insomnia in primary care patients. Sleep 1999; 22(Suppl 2): 359-365.
6. Simon GE, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry 1997; 154(10): 1417-1423.
7. Kroenke K, Mangelsdorff AD. Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome. Am J Med 1989; 86(3): 262-266.
8. The Gallup Organization, Sleep in America: A National Survey of US Adults. Los Angeles CA: National Sleep Foundation 1991.
9. Moul DE, Nofzinger EA, Pilkonis PA, Houck PR, Miewald JM, Buysse DJ. Symptom reports in severe chronic insomnia. Sleep 2002; 25(5): 553-563.
10. Roth T, Ancoli-Israel S. Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II. Sleep 1999; 22(Suppl 2): S354-S358.
11. Zammit GK, Weiner J, Damato N, Sillup GP, McMillan CA. Quality of life in people with insomnia. Sleep 1999; 22(Suppl 2): S379-S385.
12. Kapur VK, Redline S, Nieto FJ, Young TB, Newman AB, Henderson JA, Sleep Heart Health Research Group. The relationship between chronically disrupted sleep and healthcare use. Sleep 2002; 25(3): 289-296.
13. Chang PP, Ford DE, Mead LA, Cooper-Patrick L, Klag MJ. Insomnia in young men and subsequent depression The Johns Hopkins Precursors Study. Am J Epidemiol 1997; 146(2): 105-114.
14. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989; 262(11): 1479-1484.
15. Weissman MM, Greenwald S, Nino-Murcia G, Dement WC. The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry 1997; 19(4): 245-250.
16. Aikens JE, Caruana-Montaldo B, Vanable PA, Tadimeti L, Mendelson WB. MMPI correlates of sleep and respiratory disturbance in obstructive sleep apnea. Sleep 1999; 22: 362-369.
17. Aikens JE, Mendelson WB. A matched comparison of MMPI responses in patients with primary snoring or obstructive steep apnea. Sleep 1999; 22: 355-359.
18. Aikens JE, Mendelson WB, Baehr EK. Replicability of psychometric differences between obstructive steep apnea, primary snoring, and periodic limb movement disorder. J Sleep Hypn 2000; 4: 211-215.
19. Aikens JE, Vanable PA, Tadimeti L, Caruana-Montaldo B, Mendelson WB. Differential rates of psychopathological symptoms in periodic limb movement disorder, obstructive sleep apnea, psychophysiological insomnia, and insomnia with psychiatric disorder. Sleep 1999; 22: 775-780.
20. Morin C, Colecchi C, Stone J et al. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 1999; 281 (11): 991-999.
21. Torrance GW, Furlong W, Feeny D et al. Multi-attribute preference functions: health utilities index. Pharmacoeconomics 1995; 7(6): 503-520.
22. The EuroQol Group, EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990; 16(3): 199-208.
23. Brazier J, Usherwood T, Harper R et al. Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol 1998; 51(11): 1115-1128.
24. Crawford B. Impact of sleep disorders: clinical economics and sleep disorders. Sleep 1997; 20(10): 829-834.
25. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York, NY: Oxford University Press 1996.
26. Wake up America: A national steep alert, vol. 1. Executive summary and executive report. Report of the national commission on sleep disorders research. Washington DC: National Institutes of Health, US Government Printing Office; 1993.
27. Chilcott L, Shapiro C. The socioeconomic impact of insomnia. PharmacoEconomics 1996; 10(Suppl 1): 1-14.
28. Walsh J, Engelhardt C. The direct economic costs of insomnia in the United States for 1995. Sleep 1999; 22(Suppl 2): S386-S393.
29. Stoller MK. Economic effects of insomnia. Clini Ther 1994; 16(5): 873-897.
30. Leger D, Levy E, Paillard M. The direct costs of insomnia in France. Sleep 1999; 22(Suppl 2): S394-S401.
31. Walsh JK, Engelhardt CL, Hartman PG. The direct economic cost of insomnia. In: D Nutt, W Mendelson (eds.) Hypnotics and anxiolytics. London: Bailliere Tindall 1995; 369-381.
32. Sanford JRA. Tolerance of debility in elderly dependents by supporters at home: its significance for hospital practice. Br Med J 1975; 3: 471-473.
33. Pollack CP, Perlick D. Sleep problems and institutionalization of the elderly. J Geriatr Psychiatry Neurol 1991; 4: 204-210.
34. Mendelson W, Jain B. An assessment of short-acting hypnotics. Drug Saf 1995; 13(4): 257-270.
35. th edition. Thomson Medical Economics, 2002.
36. Leger D. The cost of sleep-related accidents: a report for the National Commission on Sleep Disorders Research. Sleep 1994; 17: 84-93.
37. Leger D, Scheuermaier K, Philip P et al. SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers. Psychosom Med 2001; 63: 49-55.
38. Benca R. Consequences of insomnia and its therapies. J Clin Psychiatry 2001; 62(Suppl 10): 33-38.
39. Marquis P. Steep disturbance: a component of health status. PharmacoEconomics 1996; 10(Suppl 1): 25-28.
40. Idzikowski C. Impact of insomnia on health-related quality of life. PharmacoEconomics 1996; 10(Suppl 1): 15-24.
41. Goldenberg F, Hindmarch J, Joyce CRB et al. Zopiclone, sleep and health-related quality of life. Hum Psychophormacol 1994; 9: 245-252.
42. Leger D, Quera-Salva MA, Philip P. Health-related quality of life in patients with insomnia treated with zopiclone. PharmacoEconomics 1996; 10(Suppl 1): 39-44.
43. Leger D, Janus C, Pellois A et al. Sleep, morning alertness and quality of life in subjects treated with zopiclone and in good sleepers. Study comparing 167 patients and 381 good sleepers. Eur Psychiatry 1995; 10(Suppl 3): 99s-102.
44. Walsh J, Roth T, Randazzo A et al. Eight weeks of non-nightly use of zolpidem for primary insomnia. Sleep 2000; 23(8): 1087-1096.
45. Hajak G. Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a large-scale, double-blind, randomized, outpatient study. Int Clin Psychophormacol 2002; 17: 9-17.
46. Hatoum H, Kong S, Kania C et al. Insomnia, health-related quality of life and healthcare resource consumption: a study of Managed-Care Organisation Enrollees. Pharmacoeconomics 1998; 14(6): 629-637.
47. Hajak G. Epidemiology or severe insomnia and its consequences in Germany. Eur Arch Psychiatry Clin Neurosci 2001; 251: 49-56.
48. Roth T. New trends in insomnia management. J Psychophormacol 1999; 13(4 Suppl 1): S37-S40.
49. Lichstein K, Durrence H, Riedel B. Primary versus secondary insomnia in older adults: subjective steep and daytime functioning. Psychol Aging 2001; 16(2): 264-271.
50. Katz D, McHorney C. The relationship between insomnia and health-related quality of life in patients with chronic illness. J Family Pract 2002; 51(3): 229-235.
51. National Physician Fee Schedule Relative Value File. Retrieved November 4, 2002 from Centers for Medicare and Medicaid Services site: http://cms.hhs.gov/providers/pufdownload/rvudown.asp